The global in vitro diagnostic (IVD) testing market has experienced significant growth due to the increasing demand for early disease detection, personalized healthcare, and advancements in medical technology. In vitro diagnostic testing involves analyzing samples such as blood, urine, and tissue outside the human body to detect diseases, monitor health conditions, and guide treatment decisions. The market is driven by a rise in chronic diseases such as diabetes, cancer, and cardiovascular disorders, which require ongoing monitoring and early diagnosis. Additionally, the aging global population is contributing to the growing need for diagnostic tests as older individuals are more prone to developing various health conditions. Innovations in IVD technologies, such as molecular diagnostics, point-of-care testing, and next-generation sequencing, have made diagnostic testing more accurate, accessible, and faster. The growing demand for personalized medicine, where treatments are tailored based on individual characteristics, is also fueling the growth of the IVD market. As healthcare systems across the world continue to prioritize early diagnosis and preventative care, the IVD testing market is poised for continued expansion, with new technologies and innovations driving market growth in both developed and emerging markets. Furthermore, the ongoing research and development in the field of IVD are expected to create new opportunities for testing platforms, expanding the range of diseases that can be diagnosed and managed through IVD methods.
According to Publisher, the global IVD (In Vitro Diagnostic) Testing market size was valued at US$ 14330 million in 2024. With growing demand in downstream market, the IVD (In Vitro Diagnostic) Testing is forecast to a readjusted size of US$ 23690 million by 2030 with a CAGR of 7.4% during review period. The Asia Pacific region is emerging as a key player in the global IVD testing market, primarily due to rapid economic growth, increased healthcare spending, and a growing focus on healthcare infrastructure development. Countries like China, India, and Japan have seen a surge in demand for IVD products, driven by rising healthcare awareness, government initiatives to improve healthcare access, and a large and aging population. Moreover, the increasing prevalence of chronic diseases in these countries has spurred demand for advanced diagnostic tools to enable better disease management. The IVD testing market in this region is further boosted by improvements in medical infrastructure and the adoption of digital health technologies. The presence of a strong manufacturing base and the rise of local players in the IVD space are making healthcare solutions more affordable and accessible in the region. North America and Europe remain significant markets for IVD testing, primarily driven by their advanced healthcare systems, high levels of healthcare expenditure, and strong demand for precision diagnostics. In these regions, technological advancements in diagnostic tests, particularly in molecular diagnostics and next-generation sequencing, are contributing to market growth. With increasing healthcare investments in both developed and developing nations, the global IVD testing market is expected to continue expanding, with each region playing a crucial role in the broader market dynamics.
What's Inside a Bonafide Research`s industry report?
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
The IVD testing market is segmented by types, which include clinical chemistry, immunoassays, molecular diagnostics, hematology, microbiology, and others. Clinical chemistry tests are the largest segment, as they are widely used for the diagnosis and monitoring of a variety of conditions, including diabetes, liver diseases, and kidney diseases. These tests measure specific chemicals or enzymes in blood or urine to assess organ function and detect abnormalities. Immunoassays, which detect specific antibodies or antigens in a sample, are also a critical segment, as they are extensively used in detecting infectious diseases, cancers, and autoimmune disorders. Molecular diagnostics is a rapidly growing segment, driven by advances in genetic testing and next-generation sequencing technologies. This segment is instrumental in detecting genetic disorders, infectious diseases like COVID-19, and cancer, providing highly accurate results. Hematology testing, which involves analyzing blood to diagnose blood-related disorders, is another essential category within the IVD market. Microbiology testing, which detects microbial infections, continues to play a vital role in diagnosing infectious diseases, including bacterial, viral, and fungal infections. The diversification of IVD test types is creating a more comprehensive diagnostic environment, with each category contributing to advancements in healthcare and treatment. As technological advancements continue to evolve, new types of diagnostic tests are likely to emerge, further expanding the scope of the IVD testing market across a range of healthcare settings.
The IVD testing market is also segmented by applications, which include disease diagnostics, blood glucose monitoring, pregnancy and fertility testing, infectious disease testing, and cancer diagnostics, among others. Disease diagnostics is the largest application segment, encompassing the detection of a wide range of diseases, including cardiovascular diseases, diabetes, infectious diseases, and respiratory disorders. As healthcare systems focus on early detection and disease prevention, the demand for diagnostic tests to manage chronic conditions is rising. Blood glucose monitoring is a critical application, particularly for patients with diabetes, as continuous monitoring of glucose levels is essential for effective disease management. The growing global prevalence of diabetes is driving the demand for home-based glucose monitoring devices, making this segment a key focus for the IVD market. Pregnancy and fertility testing also contribute significantly to the market, driven by advancements in over-the-counter tests and the rising awareness of reproductive health. Infectious disease testing, particularly for diseases such as HIV, hepatitis, and COVID-19, has seen significant growth due to the urgent need for fast and reliable diagnostic tools. Additionally, cancer diagnostics is a rapidly expanding segment, with molecular diagnostics offering highly precise tests for detecting various forms of cancer, enabling early intervention and personalized treatment plans. As the demand for precision medicine and early diagnosis increases, IVD applications are becoming more diverse, with a growing focus on areas such as genetic testing, organ transplantation, and personalized health management. This diversification of IVD applications is expected to drive the continued growth of the market, with advancements in diagnostic technologies improving the accuracy and efficiency of disease detection and management worldwide.
Make this report your own
Have queries/questions regarding a report
Take advantage of intelligence tailored to your business objective
Sikandar Kesari
Research Analyst
Don’t pay for what you don’t need. Save 30%
Customise your report by selecting specific countries or regions
Table 1. IVD (In Vitro Diagnostic) Testing Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Instruments
Table 3. Major Players of Reagents
Table 4. Major Players of Data Management Software
Table 5. Major Players of Services
Table 6. IVD (In Vitro Diagnostic) Testing Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 7. Global IVD (In Vitro Diagnostic) Testing Market Size by Type (2019-2024) & ($ Millions)
Table 8. Global IVD (In Vitro Diagnostic) Testing Market Size Market Share by Type (2019-2024)
Table 9. IVD (In Vitro Diagnostic) Testing Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 10. Global IVD (In Vitro Diagnostic) Testing Market Size by Application (2019-2024) & ($ Millions)
Table 11. Global IVD (In Vitro Diagnostic) Testing Market Size Market Share by Application (2019-2024)
Table 12. Global IVD (In Vitro Diagnostic) Testing Revenue by Players (2019-2024) & ($ Millions)
Table 13. Global IVD (In Vitro Diagnostic) Testing Revenue Market Share by Player (2019-2024)
Table 14. IVD (In Vitro Diagnostic) Testing Key Players Head office and Products Offered
Table 15. IVD (In Vitro Diagnostic) Testing Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global IVD (In Vitro Diagnostic) Testing Market Size by Regions 2019-2024 & ($ Millions)
Table 19. Global IVD (In Vitro Diagnostic) Testing Market Size Market Share by Regions (2019-2024)
Table 20. Global IVD (In Vitro Diagnostic) Testing Revenue by Country/Region (2019-2024) & ($ millions)
Table 21. Global IVD (In Vitro Diagnostic) Testing Revenue Market Share by Country/Region (2019-2024)
Table 22. Americas IVD (In Vitro Diagnostic) Testing Market Size by Country (2019-2024) & ($ Millions)
Table 23. Americas IVD (In Vitro Diagnostic) Testing Market Size Market Share by Country (2019-2024)
Table 24. Americas IVD (In Vitro Diagnostic) Testing Market Size by Type (2019-2024) & ($ Millions)
Table 25. Americas IVD (In Vitro Diagnostic) Testing Market Size Market Share by Type (2019-2024)
Table 26. Americas IVD (In Vitro Diagnostic) Testing Market Size by Application (2019-2024) & ($ Millions)
Table 27. Americas IVD (In Vitro Diagnostic) Testing Market Size Market Share by Application (2019-2024)
Table 28. APAC IVD (In Vitro Diagnostic) Testing Market Size by Region (2019-2024) & ($ Millions)
Table 29. APAC IVD (In Vitro Diagnostic) Testing Market Size Market Share by Region (2019-2024)
Table 30. APAC IVD (In Vitro Diagnostic) Testing Market Size by Type (2019-2024) & ($ Millions)
Table 31. APAC IVD (In Vitro Diagnostic) Testing Market Size Market Share by Type (2019-2024)
Table 32. APAC IVD (In Vitro Diagnostic) Testing Market Size by Application (2019-2024) & ($ Millions)
Table 33. APAC IVD (In Vitro Diagnostic) Testing Market Size Market Share by Application (2019-2024)
Table 34. Europe IVD (In Vitro Diagnostic) Testing Market Size by Country (2019-2024) & ($ Millions)
Table 35. Europe IVD (In Vitro Diagnostic) Testing Market Size Market Share by Country (2019-2024)
Table 36. Europe IVD (In Vitro Diagnostic) Testing Market Size by Type (2019-2024) & ($ Millions)
Table 37. Europe IVD (In Vitro Diagnostic) Testing Market Size Market Share by Type (2019-2024)
Table 38. Europe IVD (In Vitro Diagnostic) Testing Market Size by Application (2019-2024) & ($ Millions)
Table 39. Europe IVD (In Vitro Diagnostic) Testing Market Size Market Share by Application (2019-2024)
Table 40. Middle East & Africa IVD (In Vitro Diagnostic) Testing Market Size by Region (2019-2024) & ($ Millions)
Table 41. Middle East & Africa IVD (In Vitro Diagnostic) Testing Market Size Market Share by Region (2019-2024)
Table 42. Middle East & Africa IVD (In Vitro Diagnostic) Testing Market Size by Type (2019-2024) & ($ Millions)
Table 43. Middle East & Africa IVD (In Vitro Diagnostic) Testing Market Size Market Share by Type (2019-2024)
Table 44. Middle East & Africa IVD (In Vitro Diagnostic) Testing Market Size by Application (2019-2024) & ($ Millions)
Table 45. Middle East & Africa IVD (In Vitro Diagnostic) Testing Market Size Market Share by Application (2019-2024)
Table 46. Key Market Drivers & Growth Opportunities of IVD (In Vitro Diagnostic) Testing
Table 47. Key Market Challenges & Risks of IVD (In Vitro Diagnostic) Testing
Table 48. Key Industry Trends of IVD (In Vitro Diagnostic) Testing
Table 49. Global IVD (In Vitro Diagnostic) Testing Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 50. Global IVD (In Vitro Diagnostic) Testing Market Size Market Share Forecast by Regions (2025-2030)
Table 51. Global IVD (In Vitro Diagnostic) Testing Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 52. Global IVD (In Vitro Diagnostic) Testing Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 53. Siemens Healthineers Details, Company Type, IVD (In Vitro Diagnostic) Testing Area Served and Its Competitors
Table 54. Siemens Healthineers IVD (In Vitro Diagnostic) Testing Product Offered
Table 55. Siemens Healthineers IVD (In Vitro Diagnostic) Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 56. Siemens Healthineers Main Business
Table 57. Siemens Healthineers Latest Developments
Table 58. F. Hoffmann-La Roche Details, Company Type, IVD (In Vitro Diagnostic) Testing Area Served and Its Competitors
Table 59. F. Hoffmann-La Roche IVD (In Vitro Diagnostic) Testing Product Offered
Table 60. F. Hoffmann-La Roche Main Business
Table 61. F. Hoffmann-La Roche IVD (In Vitro Diagnostic) Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 62. F. Hoffmann-La Roche Latest Developments
Table 63. Danaher (Beckman Coulter Inc) Details, Company Type, IVD (In Vitro Diagnostic) Testing Area Served and Its Competitors
Table 64. Danaher (Beckman Coulter Inc) IVD (In Vitro Diagnostic) Testing Product Offered
Table 65. Danaher (Beckman Coulter Inc) Main Business
Table 66. Danaher (Beckman Coulter Inc) IVD (In Vitro Diagnostic) Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 67. Danaher (Beckman Coulter Inc) Latest Developments
Table 68. Abbott Laboratories Details, Company Type, IVD (In Vitro Diagnostic) Testing Area Served and Its Competitors
Table 69. Abbott Laboratories IVD (In Vitro Diagnostic) Testing Product Offered
Table 70. Abbott Laboratories Main Business
Table 71. Abbott Laboratories IVD (In Vitro Diagnostic) Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 72. Abbott Laboratories Latest Developments
Table 73. Thermo Fisher Scientific Details, Company Type, IVD (In Vitro Diagnostic) Testing Area Served and Its Competitors
Table 74. Thermo Fisher Scientific IVD (In Vitro Diagnostic) Testing Product Offered
Table 75. Thermo Fisher Scientific Main Business
Table 76. Thermo Fisher Scientific IVD (In Vitro Diagnostic) Testing Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 77. Thermo Fisher Scientific Latest Developments
Figure 1. IVD (In Vitro Diagnostic) Testing Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global IVD (In Vitro Diagnostic) Testing Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. IVD (In Vitro Diagnostic) Testing Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. IVD (In Vitro Diagnostic) Testing Sales Market Share by Country/Region (2023)
Figure 8. IVD (In Vitro Diagnostic) Testing Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global IVD (In Vitro Diagnostic) Testing Market Size Market Share by Type in 2023
Figure 10. IVD (In Vitro Diagnostic) Testing in Hospitals
Figure 11. Global IVD (In Vitro Diagnostic) Testing Market: Hospitals (2019-2024) & ($ Millions)
Figure 12. IVD (In Vitro Diagnostic) Testing in Ambulatory Surgical Centers
Figure 13. Global IVD (In Vitro Diagnostic) Testing Market: Ambulatory Surgical Centers (2019-2024) & ($ Millions)
Figure 14. IVD (In Vitro Diagnostic) Testing in Diagnostic Centers
Figure 15. Global IVD (In Vitro Diagnostic) Testing Market: Diagnostic Centers (2019-2024) & ($ Millions)
Figure 16. IVD (In Vitro Diagnostic) Testing in Others
Figure 17. Global IVD (In Vitro Diagnostic) Testing Market: Others (2019-2024) & ($ Millions)
Figure 18. Global IVD (In Vitro Diagnostic) Testing Market Size Market Share by Application in 2023
Figure 19. Global IVD (In Vitro Diagnostic) Testing Revenue Market Share by Player in 2023
Figure 20. Global IVD (In Vitro Diagnostic) Testing Market Size Market Share by Regions (2019-2024)
Figure 21. Americas IVD (In Vitro Diagnostic) Testing Market Size 2019-2024 ($ Millions)
Figure 22. APAC IVD (In Vitro Diagnostic) Testing Market Size 2019-2024 ($ Millions)
Figure 23. Europe IVD (In Vitro Diagnostic) Testing Market Size 2019-2024 ($ Millions)
Figure 24. Middle East & Africa IVD (In Vitro Diagnostic) Testing Market Size 2019-2024 ($ Millions)
Figure 25. Americas IVD (In Vitro Diagnostic) Testing Value Market Share by Country in 2023
Figure 26. United States IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 27. Canada IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 28. Mexico IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 29. Brazil IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 30. APAC IVD (In Vitro Diagnostic) Testing Market Size Market Share by Region in 2023
Figure 31. APAC IVD (In Vitro Diagnostic) Testing Market Size Market Share by Type in 2023
Figure 32. APAC IVD (In Vitro Diagnostic) Testing Market Size Market Share by Application in 2023
Figure 33. China IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 34. Japan IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 35. Korea IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 36. Southeast Asia IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 37. India IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 38. Australia IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 39. Europe IVD (In Vitro Diagnostic) Testing Market Size Market Share by Country in 2023
Figure 40. Europe IVD (In Vitro Diagnostic) Testing Market Size Market Share by Type (2019-2024)
Figure 41. Europe IVD (In Vitro Diagnostic) Testing Market Size Market Share by Application (2019-2024)
Figure 42. Germany IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 43. France IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 44. UK IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 45. Italy IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 46. Russia IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 47. Middle East & Africa IVD (In Vitro Diagnostic) Testing Market Size Market Share by Region (2019-2024)
Figure 48. Middle East & Africa IVD (In Vitro Diagnostic) Testing Market Size Market Share by Type (2019-2024)
Figure 49. Middle East & Africa IVD (In Vitro Diagnostic) Testing Market Size Market Share by Application (2019-2024)
Figure 50. Egypt IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 51. South Africa IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 52. Israel IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 53. Turkey IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 54. GCC Country IVD (In Vitro Diagnostic) Testing Market Size Growth 2019-2024 ($ Millions)
Figure 55. Americas IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 56. APAC IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 57. Europe IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 58. Middle East & Africa IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 59. United States IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 60. Canada IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 61. Mexico IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 62. Brazil IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 63. China IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 64. Japan IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 65. Korea IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 66. Southeast Asia IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 67. India IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 68. Australia IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 69. Germany IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 70. France IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 71. UK IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 72. Italy IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 73. Russia IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 74. Spain IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 75. Egypt IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 76. South Africa IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 77. Israel IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 78. Turkey IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 79. GCC Countries IVD (In Vitro Diagnostic) Testing Market Size 2025-2030 ($ Millions)
Figure 80. Global IVD (In Vitro Diagnostic) Testing Market Size Market Share Forecast by Type (2025-2030)
Figure 81. Global IVD (In Vitro Diagnostic) Testing Market Size Market Share Forecast by Application (2025-2030)
One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information
One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information
Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information
All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information